Providing Report on the Pricing of Branded Pharmaceuticals in England and Wales

The Association of the British Pharmaceutical Industry (ABPI) commissioned a report from NERA on possible economic inefficiencies in government proposals for the statutory scheme that determines payment for some pharmaceuticals bought by the NHS in England and Wales. A summary of our finding was published by ABPI.